# Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers

> **NCT02801981** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 16 (actual)

## Conditions studied

- Cholestasis

## Interventions

- **DRUG:** GSK2230672
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02801981
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02801981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02801981, "Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02801981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*